Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.5390
-0.0322 (-5.64%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Biodesix Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 26.25 | 26.28 | 43.09 | 32.71 | 62.13 | Upgrade
|
| Cash & Short-Term Investments | 26.25 | 26.28 | 43.09 | 32.71 | 62.13 | Upgrade
|
| Cash Growth | -0.15% | -39.00% | 31.72% | -47.35% | 1075.29% | Upgrade
|
| Receivables | 8.6 | 7.68 | 5.07 | 3.66 | 15.3 | Upgrade
|
| Inventory | 1 | 1.4 | 1.4 | 2.9 | 3.2 | Upgrade
|
| Restricted Cash | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | Upgrade
|
| Other Current Assets | 3.54 | 4.22 | 3.68 | 4.25 | 5.31 | Upgrade
|
| Total Current Assets | 39.48 | 39.68 | 53.33 | 43.61 | 86.14 | Upgrade
|
| Property, Plant & Equipment | 29.6 | 29.61 | 8.82 | 4.18 | 3.18 | Upgrade
|
| Goodwill | 15.03 | 15.03 | 15.03 | 15.03 | 15.03 | Upgrade
|
| Other Intangible Assets | 5.87 | 7.91 | 9.8 | 11.62 | 13.26 | Upgrade
|
| Long-Term Deferred Charges | 0.7 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 6.56 | 6.86 | 5.92 | 1.66 | 3.46 | Upgrade
|
| Total Assets | 97.24 | 99.1 | 92.91 | 76.1 | 121.07 | Upgrade
|
| Accounts Payable | 2.19 | 2.93 | 1.69 | 1.66 | 8.96 | Upgrade
|
| Accrued Expenses | 9.91 | 7.71 | 8.22 | 7.67 | 7.79 | Upgrade
|
| Current Portion of Long-Term Debt | 0.02 | 0.05 | 0.05 | 0.02 | 11.84 | Upgrade
|
| Current Portion of Leases | 1.51 | 0.25 | 1.54 | - | - | Upgrade
|
| Current Unearned Revenue | 0.68 | 0.32 | 0.96 | 1.85 | 3.53 | Upgrade
|
| Other Current Liabilities | - | 22.15 | 10.38 | 17.76 | - | Upgrade
|
| Total Current Liabilities | 14.32 | 33.42 | 22.84 | 28.96 | 32.13 | Upgrade
|
| Long-Term Debt | 36.41 | 35.23 | 25 | 9.99 | 15.93 | Upgrade
|
| Long-Term Leases | 25.44 | 25.16 | 5.25 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 0.2 | 0.3 | 0.4 | 0.8 | 1.4 | Upgrade
|
| Other Long-Term Liabilities | - | 0.41 | 18.8 | 16.62 | 30.45 | Upgrade
|
| Total Liabilities | 76.37 | 94.52 | 72.3 | 56.37 | 79.9 | Upgrade
|
| Common Stock | 0.15 | 0.1 | 0.08 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 483.23 | 424.05 | 387.95 | 321.67 | 299.95 | Upgrade
|
| Retained Earnings | -462.5 | -419.57 | -367.42 | -301.97 | -258.81 | Upgrade
|
| Total Common Equity | 20.88 | 4.58 | 20.61 | 19.73 | 41.17 | Upgrade
|
| Shareholders' Equity | 20.88 | 4.58 | 20.61 | 19.73 | 41.17 | Upgrade
|
| Total Liabilities & Equity | 97.24 | 99.1 | 92.91 | 76.1 | 121.07 | Upgrade
|
| Total Debt | 63.38 | 60.69 | 31.85 | 10.01 | 27.77 | Upgrade
|
| Net Cash (Debt) | -37.14 | -34.41 | 11.24 | 22.7 | 34.36 | Upgrade
|
| Net Cash Growth | - | - | -50.49% | -33.93% | - | Upgrade
|
| Net Cash Per Share | -0.29 | -0.42 | 0.27 | 0.83 | 7.10 | Upgrade
|
| Filing Date Shares Outstanding | 145.98 | 96.94 | 77.97 | 31.31 | 26.58 | Upgrade
|
| Total Common Shares Outstanding | 145.49 | 96.24 | 77.61 | 30.79 | 26.56 | Upgrade
|
| Working Capital | 25.17 | 6.27 | 30.5 | 14.65 | 54.02 | Upgrade
|
| Book Value Per Share | 0.14 | 0.05 | 0.27 | 0.64 | 1.55 | Upgrade
|
| Tangible Book Value | -0.03 | -18.36 | -4.22 | -6.92 | 12.88 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | -0.19 | -0.05 | -0.22 | 0.48 | Upgrade
|
| Machinery | 8.36 | 8.44 | 7.23 | 7.97 | 7.03 | Upgrade
|
| Construction In Progress | 0.09 | - | 2.95 | 0.02 | 0.38 | Upgrade
|
| Leasehold Improvements | 28.19 | 24.71 | 2.37 | 2.34 | 1.85 | Upgrade
|
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.